Since there was no obvious correlation between Ki-67 expression and clinicopathological characteristics of SCCE (including TNM stage), we therefore investigated further on the role of adjuvant therapy in both high Ki-67 index group and low Ki-67 index group. This evidence concerns the gene MKI67 and cervical small cell carcinoma.